Sentences with phrase «focuses on cardiovascular disease»
Gladstone, which is affiliated with UCSF, is a leading and independent biomedical - research organization that focuses on cardiovascular disease, neurodegenerative disease and viral infections.
https://gladstone.org/
Major diabetic complications will be discussed with emphasis on known sexual dimorphism and gender differences will focus on cardiovascular disease (CVD), cardiomyopathy, and nephropathy.
Not exact matches
And even though few studies focus on the benefits of chia seeds on cardiovascular diseases, most of them conclude that these black specks are a safe bet when it comes to heart - friendly nutrition.
His research focuses on two major themes: (a) clinical research in cardiovascular disease and diabetes and (b) research related to food policy and the dietary determinants of ill health.
«The field of occupational travel medicine needs to expand beyond its current focus on infectious disease, cardiovascular disease risks, violence and injury to bring more focus to the behavioral and mental health consequences of business travel.»
The researchers focused on specific cardiovascular disease diagnoses: myocardial infarction (heart attack), chronic heart failure, stroke, and ischemic heart disease.
Past research has largely looked at people with existing cardiovascular disease (prevalent disease), rather than focusing on those newly diagnosed (incident disease).
These subprojects will focus on aging - associated diseases (such as Alzheimer's disease, cardiovascular diseases, diabetes, muscle weakness) and on various forms of cancer such as neuroblastoma, colon, or breast cancer.
An internist and researcher with more than 650 peer - reviewed publications to his credit, Siscovick focuses broadly on the epidemiology and prevention of cardiovascular disease across the lifespan and multi-sectorial social determinants of health.
They also used World Health Organization spreadsheets «that would tell us how many people would develop cardiovascular disease or mild mental retardation from those levels,» sayslead author Kevin Chatham - Stephens, a pediatrician at The Mount Sinai Hospital who focuses on environmental health.
In addition, the survey found that healthcare providers more often focused on a woman's weight rather than other cardiovascular disease risk factors, compared to men who were more likely to be told their cholesterol or blood pressure is too high by their doctors.
Forthcoming research planned by the group will focus on isolated vitamin D supplementation and indicators of cardiovascular disease in postmenopausal women.
«Scientific findings from the past two decades that focused on the prevention of cardiovascular diseases continue to show that among people who are at risk of dying from heart disease, the potential benefit of omega - 3 fish oil supplements is still useful for people who have had a recent heart attack, which is consistent with the 2002 statement,» Siscovick said.
Their research focused on type 1 diabetes, for which cardiovascular disease accounts for 65 — 75 % of deaths.
Dr. Saptarsi Haldar's research focuses on how cells in the cardiovascular system control gene expression and how these gene control mechanisms go awry during disease.
Our laboratory focuses on understanding gene regulation in the cardiovascular system, skeletal muscle, and other metabolic tissues, with the ultimate goal of finding novel therapeutic strategies to prevent and treat cardio - metabolic and - myopathic diseases.
AstraZeneca is a global, innovation - driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - respiratory, inflammation, autoimmune disease, cardiovascular and metabolic disease and oncology — as well as in infection and neuroscience.
Dr. Conklin's research focuses on human genetics that lead to cardiovascular diseases, such as cardiac arrhythmias and cardiomyopathy.
Previously, Mr. Field was the President / CEO of two biotechnology companies focused on the development of therapeutics in the cardiovascular, cancer and respiratory diseases areas.
Our research is focused on understanding how the functions of immune cells, such as monocytes and T lymphocytes, change during the progression of cardiovascular disease and cancer.
Check out our special collection of journal articles published in 2016 — 2017, focused on cardiovascular endocrinology, and the links below to stay informed on news, patient resources and educational opportunities as our understanding and treatment of vascular disease continues to evolve while patients benefit.
One research program focuses on the role of myeloperoxidase, a leukocyte heme protein, in promoting oxidant stress in vivo, and its participation in cardiovascular diseases.
Susan Amara, USA - «Regulation of transporter function and trafficking by amphetamines, Structure - function relationships in excitatory amino acid transporters (EAATs), Modulation of dopamine transporters (DAT) by GPCRs, Genetics and functional analyses of human trace amine receptors» Tom I. Bonner, USA (Past Core Member)- Genomics, G protein coupled receptors Michel Bouvier, Canada - Molecular Pharmacology of G protein - Coupled Receptors; Molecular mechanisms controlling the selectivity and efficacy of GPCR signalling Thomas Burris, USA - Nuclear Receptor Pharmacology and Drug Discovery William A. Catterall, USA (Past Core Member)- The Molecular Basis of Electrical Excitability Steven Charlton, UK - Molecular Pharmacology and Drug Discovery Moses Chao, USA - Mechanisms of Neurotophin Receptor Signaling Mark Coles, UK - Cellular differentiation, human embryonic stem cells, stromal cells, haematopoietic stem cells, organogenesis, lymphoid microenvironments, develomental immunology Steven L. Colletti, USA Graham L Collingridge, UK Philippe Delerive, France - Metabolic Research (diabetes, obesity, non-alcoholic fatty liver, cardio - vascular diseases, nuclear hormone receptor, GPCRs, kinases) Sir Colin T. Dollery, UK (Founder and Past Core Member) Richard M. Eglen, UK Stephen M. Foord, UK David Gloriam, Denmark - GPCRs, databases, computational drug design, orphan recetpors Gillian Gray, UK Debbie Hay, New Zealand - G protein - coupled receptors, peptide receptors, CGRP, Amylin, Adrenomedullin, Migraine, Diabetes / obesity Allyn C. Howlett, USA Franz Hofmann, Germany - Voltage dependent calcium channels and the positive inotropic effect of beta adrenergic stimulation; cardiovascular function of cGMP protein kinase Yu Huang, Hong Kong - Endothelial and Metabolic Dysfunction, and Novel Biomarkers in Diabetes, Hypertension, Dyslipidemia and Estrogen Deficiency, Endothelium - derived Contracting Factors in the Regulation of Vascular Tone, Adipose Tissue Regulation of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) transporters
To begin their work as a CCDG, Kathiresan, Gabriel, Daly, Lander, and their colleagues, awarded $ 80 million over four years, will focus on a handful of diseases in three core areas, including cardiovascular disease, inflammatory disease, and neuropsychiatric disease.
Metabolic research focuses on better understanding basic biological mechanisms that regulate metabolism and how they are dysregulated in disorders such as obesity, diabetes, cardiovascular disease, and cancer.
It primarily focuses on normalizing blood glucose levels, which is key to promoting healthy weight loss and preventing the onset or progression of insulin resistance and related health issues and cardiovascular disease risk factors with the benefit of Soothe Digest for improved digestion.
In this episode Rhonda talks about how heat stress from using the sauna makes the body more resilient to the stresses of aging, possible reasons why one study associated sauna use with up to a 40 % lower all - cause mortality as well as a 50 % lower cardiovascular disease related mortality, how it enhances athletic endurance, staves off muscle atrophy, improves regrowth of muscle after disuse, and some of the profound effects on the brain, including the growth of new brain cells, improvement in focus, learning, and memory, and even potentially ameliorating depression and anxiety.
«'' Although dietary recommendations have focused on restricting saturated fat (SF) consumption to reduce cardiovascular disease (CVD) risk, evidence from prospective studies has not supported a strong link between total SF intake and CVD events... A higher intake of dairy SF was associated with LOWER CVD risk.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396447/ — «Although dietary recommendations have focused on restricting saturated fat (SF) consumption to reduce cardiovascular disease (CVD) risk, evidence from prospective studies has not supported a strong link between total SF intake and CVD events... A higher intake of dairy SF was associated with LOWER CVD risk.
Love this article as my practice focuses primarily on cardiovascular disease, with of course foundational support to address root cause.
The answer lies in a new breakthrough program that focuses on lifestyle changes that improve the function of our arteries to prevent and reverse cardiovascular disease.
His primary focus is on risk assessment, prevention, and drug - free treatment strategies for cardiovascular disease and diabetes, as well as general healthy aging.
In addition to her specialized focus on Lyme disease, she also treats a broad spectrum of other disorders like autoimmunity, gastrointestinal problems, cardiovascular disease, neurological issues, and adrenal and thyroid dysfunction.
Randomized clinical trials and epidemiologic studies have shown that individuals who consume higher amounts of added sugar, especially sugar - sweetened beverages, tend to gain more weight7 and have a higher risk of obesity,2,8 - 13 type 2 diabetes mellitus,8,14 - 17 dyslipidemias, 18,19 hypertension, 20,21 and cardiovascular disease (CVD).14, 22 Most previous studies have focused on sugar - sweetened beverages but not total added sugar, and none of these studies has used nationally representative samples to examine the relationship between added sugar intake and CVD mortality.
In this Handbook of Experimental Pharmacology on «High Density Lipoproteins — from biological understanding to clinical exploitation» contributing authors (members of COST Action BM0904 / HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation.The book is of interest to researchers in academia and industry focusing on lipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases...
Ten grants will be awarded to pre-proposals focusing on the health effects of animals on humans with the following conditions: autism, cancer, cardiovascular disease, dementia / Alzheimer's, depression, post-traumatic stress disorder (PTSD), or childhood allergies and immunity.
The faculty research tends to focus on such public health issues as TB, obesity, and cardiovascular disease, though that focus is expanding into new research areas such as genetics and how the field impacts communicable disease.
About Blog Heart is an international peer - reviewed journal focussing on advances in the diagnosis and treatment of cardiovascular disease.